4CMenB journey to the 10-year anniversary and beyond

• Main Authors: Véronique Abitbol (Author), Federico Martinón-Torres (Author), Muhamed-Kheir Taha (Author), Terry Nolan (Author), Alessandro Muzzi (Author), Stefania Bambini (Author), Ray Borrow (Author), Daniela Toneatto (Author), Laura Serino (Author), Rino Rappuoli (Author), Mariagrazia Pizza (Author)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

The 4-component meningococcal serogroup B (MenB) vaccine, 4CMenB, the first broadly protective, protein-based MenB vaccine to be licensed, is now registered in more than 50 countries worldwide. Real-world evidence (RWE) from the last decade confirms its effectiveness and impact, with infant immuniza...